Health
FDA Approves Bayer's Sunharbo, the First Factor XIa Inhibitor, to Help Prevent a Second Stroke
A once-daily pill taken with antiplatelet therapy cut ischemic stroke risk by 26% in a 12,327-person trial.
Bayer News
All Happy News Company coverage of Bayer: the latest health news, with links to every original source.
Got good news? Let's share it.
Publish your impact story, donation, milestone or community launch on Happy News Company from $99. Nonprofits save 25%.